Position in GILD
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$5,306
-$547 QoQ
Shares Held
42
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,218
of 2,266 holders
Holding Since
Sep 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FINANCIAL CORP /IN/ holds $10,663,305 across 12 Drug Manufacturers - General names. GILD ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,212 | $5,051,998 | |
| 2 | ABBV |
AbbVie Inc.
|
9,288 | $2,337,231 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,730 | $1,507,305 | |
| 4 | JNJ |
Johnson & Johnson
|
2,095 | $532,067 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,635 | $497,548 | |
| 6 | NVO |
Novo Nordisk A S
|
6,470 | $310,171 | |
| 7 | PFE |
Pfizer Inc
|
10,210 | $245,856 | |
| 8 | NVS |
Novartis AG
|
599 | $93,875 |
All Filings in GILD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,306 | 42 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $5,853 | 42 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $9,450 | 77 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $8,547 | 77 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $8,536 | 77 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $82,804 | 739 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $68,261 | 739 | Shares | Sole | 2025-01-13 | |
| 2024-06-30 | $44,939 | 655 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $47,978 | 655 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $53,061 | 655 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $49,085 | 655 | Shares | Sole | 2023-10-11 | |
| 2020-09-30 | $15,797 | 250 | Shares | Sole | 2020-10-13 | |
| No filing history on record for this holder in this stock. | ||||||